Delivery Order 36F79724D0159-15B50525F00000136
Award Date
5/9/25
Potential Completion Date
5/9/25
Potential Value
$50K
Federal Agency
Federal Medical Center Carswell
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q517 - Pharmacy Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc. The $72,226.86 fixed-price delivery order is for the procurement of various medications used to treat pulmonary arterial hypertension, including Opsumit, Uptravi, and Adempas. The contract does not utilize a small business set-aside. Actelion Pharmaceuticals US, Inc. is a for-profit pharmaceutical manufacturer that specializes in developing...
This federal contract award is for the delivery of pharmaceutical products to the Federal Medical Center Carswell, a civilian agency under the Department of Justice. The prime contractor, Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer, is providing a variety of medications used to treat pulmonary arterial hypertension, including Opsumit, Uptravi, and Adempas. The contract, valued at $72,226.86, is a firm fixed-price delivery order placed against Actelion's Federal...
This federal contract award, valued at $72,516.33, was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc., a large for-profit pharmaceutical manufacturer. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs (VA), which has a total potential value of $219,108,390 over the period of August 2024 to July 2029. The contract provides for...
This is a firm fixed-price delivery order awarded by the Federal Medical Center Carswell, a civilian federal agency, to Actelion Pharmaceuticals US, Inc., a pharmaceutical manufacturer. The order is for the supply of critical medications used to treat pulmonary arterial hypertension, including Opsumit, Uptravi, and Adempas. The total ceiling value of the order is $72,226.86, with a period of performance through October 31, 2024. The award is placed against Actelion Pharmaceuticals' Federal...
This federal contract award is to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, specifically for the delivery of Opsumit 10mg 30-count bottles. The contract has a ceiling value of $39,098.68 and is a delivery order issued against Actelion's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), a $105 million, five-year contract vehicle. The order is placed by the Federal Medical Center Carswell, a civilian federal...
This contract was awarded by the Department of Justice Bureau of Prisons Federal Medical Center Carswell to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, including treatments for pulmonary arterial hypertension. The award is for the supply of Curascript, Opsumit 10mg 30-count bottles, with a potential value of $117,296.04. The contract is a delivery order placed against Actelion's $105 million Federal Supply Schedule (FSS-61-IB) contract for...
The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $27,152 delivery order to Actelion Pharmaceuticals US, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule. The delivery order is for the purchase of Opsumit 10mg tablets to be delivered to the company's Lake Mary, Florida facility by August 31, 2023. Actelion Pharmaceuticals will provide the pulmonary arterial hypertension medication to support medical care operations at the Carswell correctional...
This federal contract award, valued at $171,510.26, was issued by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The award is a Blanket Purchase Agreement (BPA) call order under Actelion's existing $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the supply of UPTRAVI 1600MCG TABLET, a medication used to treat pulmonary arterial hypertension. This award is...
This is a firm fixed-price delivery order contract awarded by the Department of Justice Bureau of Prisons Federal Medical Center Carswell to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products. The contract is for the delivery of 60-count bottles of UPTRAVI 1600MCG, a medication used to treat pulmonary arterial hypertension. The potential value of this order is $19,535.58, with a performance period ending on April 30, 2024. Actelion Pharmaceuticals US, Inc....
This is a $351,244.44 firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The order is for specialty medication, primarily treatments for pulmonary arterial hypertension, which are critical drugs for VA medical centers and other federal healthcare facilities. The contract is placed against Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs...